IQ-AI Limited (IQAI.L)

GBp 0.75

(-10.18%)

Market Cap (In GBp)

1.85 Million

Revenue (In GBp)

609.39 Thousand

Net Income (In GBp)

-623.81 Thousand

Avg. Volume

699.49 Thousand

Currency
GBp
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.932-5.148
PE
-
EPS
-
Beta Value
2.371
ISIN
JE00BD4H0R42
CUSIP
G4R39N100
CIK
-
Shares
246710000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Mr. Trevor Edward Brown M.B.A.
Employee Count
-
Website
https://www.imagingbiometrics.com/iq-ai-ltd
Ipo Date
1993-08-02
Details
IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and IB StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient's kidney stone. In addition, it provides consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. IQ-AI Limited is based in Saint Helier, Jersey.